비교리스트

 카트 문의
시장보고서
상품코드
1565674

노출전 예방(PrEP) 시장 : 제품 유형별, 사용 유형별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Pre-Exposure Prophylaxis (PrEP) Market, By Product Type, By Usage Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 301 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

리포트 하이라이트

노출전 예방(PrEP) 시장 규모는 2023년에 49억 8,043만 달러에 달하며, 2024-2032년 CAGR 12.30%로 확대

노출전 예방(PrEP) 시장 - 시장 역학

PrEP 유효성과 가용성에 관한 인식과 교육의 향상

PrEP의 효과와 가용성에 대한 인식과 교육이 높아지면서 PrEP 시장이 크게 성장하고 있으며, 더 많은 사람들이 PrEP가 어떻게 HIV를 예방할 수 있는지 이해함에 따라 약품에 대한 수요가 증가하고 있습니다. 미국 질병통제예방센터(CDC)는 인식 개선 캠페인이 고위험군 집단에서 PrEP 사용이 크게 증가했다고 보고했습니다.

미국 질병통제예방센터(CDC)는 2021년 현재 HIV 고위험군 중 거의 60%가 PrEP를 알고 있다고 보고했으며, CDC는 또한 2018년에서 2021년 사이에 PrEP 처방이 25% 증가했다고 지적했는데, 이는 이 예방 치료에 대한 인식과 보급이 증가하고 있음을 반영합니다. 확산이 증가하고 있음을 반영합니다. 이러한 인식과 사용 증가는 PrEP 시장 확대의 중요한 요소입니다.

Pre-exposure prophylaxis(PrEP) 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면 세계 시장은 예측 기간(2024-2032) 동안 매년 약 12.30%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

제품 유형별로는 브랜드 PrEP가 22023년 가장 높은 시장 점유율을 차지했습니다.

사용 유형에 따르면 2023년 경구용 PrEP는 1일 1회 복용이 주요 유형으로 나타났습니다.

지역별로는 북미가 2023년 매출에서 선두를 차지했습니다.

노출전 예방(PrEP) 시장 - 세분화 분석 :

세계 노출전 예방(PrEP) 시장은 제품 유형, 사용 유형, 최종사용자 및 지역에 따라 세분화됩니다.

시장은 제품 유형에 따라 제네릭 PrEP와 브랜드 PrEP의 두 가지 범주로 나뉩니다. 노출전 예방(PrEP) 시장에서는 현재 브랜드 PrEP 분야가 가장 우세합니다. 이는 Truvada 및 Descovy와 같은 브랜드 제품 시장에서의 존재감과 광범위한 홍보에 기인합니다. 브랜드 PrEP는 확립된 브랜드 인지도, 종합적인 임상 지원 및 광범위한 유통망을 통해 혜택을 누리고 있습니다. 또한 효과와 안전성이 입증되어 의료 서비스 프로바이더가 우선적으로 추천하는 경우가 많습니다. 반면, 제네릭 PrEPs는 가용성은 증가하고 있지만, 브랜드 인지도가 낮고 종합적인 지원을 받지 못할 수 있으므로 시장 점유율을 확보하는 데 여전히 어려움을 겪고 있습니다.

시장은 사용 유형에 따라 두 가지 범주로 나뉩니다. 장기 지속형 주사제 노출전 예방약(PrEP) 시장에서는 현재 경구용 경구용 PrEP 분야가 가장 우위를 점하고 있습니다. 이러한 우위는 트루바다, 데스코비 등 경구용 PrEP가 수년간 사용되어 임상적으로 검증되어 왔으며, 효과와 안전성에 대한 입증된 실적을 보유하고 있기 때문입니다. 일본 경구용 PrEP는 널리 이용 가능하고 의료진에 의해 받아들여지고 있으므로 시장 점유율이 높습니다. 장기 지속형 주사제 또한 부상하고 있지만, 시장에 진입한 지 얼마 되지 않았고 장기적인 데이터 포인트가 부족해 아직 시장 침투력이 높지 않은 상황입니다.

Pre-exposure prophylaxis(PrEP) 시장 - 지역적 인사이트

노출전 예방(PrEP) 시장의 가장 규모가 큰 지역은 북미, 특히 미국입니다. 이 지역이 선두를 달리고 있는 이유는 높은 수준의 의료 인프라, HIV 예방에 대한 높은 인식, 공중 보건 구상의 강력한 지원 때문입니다. 미국은 또한 PrEP 치료제 연구개발에 많은 투자를 하고 있습니다. 다양한 의료 프로그램 및 보험 적용을 통해 PrEP를 이용할 수 있다는 점이 PrEP의 보급을 더욱 촉진하고 있습니다. 북미 시장의 우위는 강력한 규제 프레임워크와 PrEP 사용을 장려하는 적극적인 지지 단체가 지원하고 있습니다.

Pre-exposure prophylaxis(PrEP) 시장 - 경쟁 구도:

노출전 예방(PrEP) 시장은 경쟁이 치열하고 여러 대기업이 시장을 독점하고 있으며, 길리어드 사이언스(Gilead Sciences, Inc.)는 PrEP 제품인 트루바다(Truvada)와 새로운 제형인 데스코비(Descovy)로 선두를 달리고 있습니다. 비브헬스케어는 장시간 지속형 주사제 PrEP인 아프레튜드로 그 뒤를 잇고 있습니다. 브리스톨마이어스스퀴브와 얀센제약도 현재 진행 중인 연구와 잠재적인 PrEP 개발로 중요한 역할을 하고 있습니다. 머크와 애브비는 HIV 연구와 새로운 PrEP 솔루션으로 기여하고 있으며, Roche와 Pfizer는 HIV 치료에 관여하고 PrEP 시장에 영향을 미치고 있으며, Sage Therapeutics와 Moderna, Inc. Mylan N.V., Hikma Pharmaceuticals, Cipla Limited, Aurobindo Pharma는 제네릭 PrEP의 선택권을 제공하고 접근성과 경제성을 확대하기 위해 노력하고 있습니다. 이 경쟁의 특징은 HIV 예방 및 치료 결과를 개선하기 위한 지속적인 혁신과 개발입니다.

목차

제1장 노출전 예방(PrEP) 시장 개요

  • 조사 범위
  • 시장 추정년

제2장 개요

  • 시장 내역
  • 경쟁 인사이트

제3장 노출전 예방(PrEP)의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 향후 동향

제4장 노출전 예방(PrEP) 업계 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 지도제작
  • 규제 구조 분석

제5장 노출전 예방(PrEP) 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 노출전 예방(PrEP) 시장 구도

  • 노출전 예방(PrEP) 시장 점유율 분석, 2023년
  • 주요 제조업체별 내역 데이터
    • 기존 기업의 분석
    • 신규 기업의 분석

제7장 노출전 예방(PrEP) 시장 - 제품 유형별

  • 개요
    • 제품 유형별 부문 점유율 분석
    • 제네릭 PrEP
    • 브랜드 PrEP

제8장 노출전 예방(PrEP) 시장 - 사용 유형별

  • 개요
    • 사용 유형별 부문 점유율 분석
    • 매일 경구 PrEP
    • 장시간 작용형 주사제

제9장 노출전 예방(PrEP) 시장 - 최종사용자별

  • 개요
    • 최종사용자별 부문 점유율 분석
    • 병원과 진료소
    • 지역 보건 센터
    • 전문 HIV 클리닉

제10장 노출전 예방(PrEP) 시장 - 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - 노출전 예방(PrEP) 업계

  • 경쟁 대시보드
  • 기업 개요
    • Gilead Sciences, Inc.
    • ViiV Healthcare
    • Bristol-Myers Squibb
    • Janssen Pharmaceuticals
    • Merck &Co., Inc.
    • AbbVie Inc.
    • Roche
    • Pfizer Inc.
    • Sage Therapeutics
    • Moderna, Inc.
    • Mylan NV
    • Hikma Pharmaceuticals
    • Cipla Limited
    • Aurobindo Pharma

제12장 애널리스트의 전방위 전망

KSA 24.10.22

REPORT HIGHLIGHT

Pre-Exposure Prophylaxis (PrEP) Market size was valued at USD 4,980.43 Million in 2023, expanding at a CAGR of 12.30% from 2024 to 2032.

Pre-exposure prophylaxis (PrEP) is a preventive treatment for high-risk individuals to reduce HIV infection. It involves taking a daily pill containing antiretroviral drugs. The PrEP market includes developing, manufacturing, and distributing these medications. This market has expanded due to increased HIV prevention awareness and access. Key players include pharmaceutical companies and healthcare providers. Ongoing research aims to improve PrEP options and explore new formulations.

Pre-Exposure Prophylaxis (PrEP) Market- Market Dynamics

Increased awareness and education about PrEP's effectiveness and availability.

Increased awareness and education about PrEP's effectiveness and availability significantly drive the PrEP market. As more people understand how PrEP can prevent HIV, demand for the drug rises. the Centers for Disease Control and Prevention (CDC) reported that increased awareness campaigns led to a substantial rise in PrEP use among high-risk populations.

The U.S. Centers for Disease Control and Prevention (CDC) reported that as of 2021, nearly 60% of individuals at high risk of HIV were aware of PrEP. The CDC also noted a 25% increase in PrEP prescriptions from 2018 to 2021, reflecting this preventive treatment's growing awareness and adoption. This rise in awareness and utilization is a key driver for the expanding PrEP market.

Pre-Exposure Prophylaxis (PrEP) Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.30% over the forecast period (2024-2032)

Based on product type segmentation, branded PrEP was predicted to show maximum market share in the year 2023

Based on Usage Type segmentation, daily oral PrEP was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Pre-Exposure Prophylaxis (PrEP) Market- Segmentation Analysis:

The Global Pre-Exposure Prophylaxis (PrEP) Market is segmented on the basis of Product Type, Usage Type, End User, and Region.

The market is divided into two categories based on product type Generic PrEP, Branded PrEP. In the Pre-Exposure Prophylaxis (PrEP) market, the branded PrEP segment is currently the most dominant. This is largely due to the strong market presence and extensive promotion of branded products like Truvada and Descovy. Branded PrEPs benefit from established brand recognition, comprehensive clinical support, and extensive distribution networks. They also often receive preferential recommendations from healthcare providers due to their proven efficacy and safety profiles. In contrast, generic PrEPs, while increasing in availability, still face challenges in gaining market share due to lower brand recognition and potentially less comprehensive support.

The market is divided into two categories based on the Usage Type Daily Oral PrEP. Long-Acting Injectables In the Pre-Exposure Prophylaxis (PrEP) market, the daily oral PrEP segment is currently the most dominant. This dominance stems from the long-standing use and clinical validation of daily oral PrEP, such as Truvada and Descovy, which have a well-established track record for efficacy and safety. Daily oral PrEP is widely available and accepted by healthcare providers, contributing to its significant market share. Long-acting injectables are emerging but have not yet achieved the same level of market penetration due to newer market entry and fewer long-term data points.

Pre-Exposure Prophylaxis (PrEP) Market- Geographical Insights

The largest region for the Pre-Exposure Prophylaxis (PrEP) market is North America, particularly the United States. This region leads due to its advanced healthcare infrastructure, high awareness of HIV prevention, and strong support from public health initiatives. The U.S. also benefits from significant investments in research and development for PrEP medications. The availability of PrEP through various healthcare programs and insurance coverage further boosts its adoption. North America's market dominance is supported by robust regulatory frameworks and active advocacy groups promoting PrEP usage.

Pre-Exposure Prophylaxis (PrEP) Market- Competitive Landscape:

The Pre-Exposure Prophylaxis (PrEP) market is highly competitive, with several major players dominating the landscape. Gilead Sciences, Inc.leads with its PrEP product, Truvada, and its newer formulation, Descovy. ViiV Healthcare follows with Apretude, a long-acting injectable PrEP option. Bristol-Myers Squibb and Janssen Pharmaceuticals are also significant, with ongoing research and potential PrEP developments. Merck & Co., Inc. and AbbVie Inc. contribute through their HIV research and emerging PrEP solutions. Roche and Pfizer Inc. are involved in HIV treatments, influencing the PrEP market. Sage Therapeutics and Moderna, Inc. are innovative players exploring new prevention methods. Mylan N.V., Hikma Pharmaceuticals, Cipla Limited, and Aurobindo Pharma provide generic PrEP options, expanding access and affordability. This competitive landscape is characterized by continuous innovation and development aimed at improving prevention and treatment outcomes for HIV.

Recent Developments:

In September 2024, with yet another phase 3 victory, Gilead is racing to introduce a long-acting PrEP medication in 2025.

In April 2023, Merck & Co. (MRK.N) said that it will acquire Prometheus Biosciences Inc. (RXDX.O) for approximately $10.8 billion. The acquisition will allow Merck to expand its foothold in immunology and acquire a potential experimental treatment for ulcerative colitis and Crohn's disease.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Gilead Sciences, Inc.
  • ViiV Healthcare
  • Bristol-Myers Squibb
  • Janssen Pharmaceuticals
  • Merck & Co., Inc.
  • AbbVie Inc.
  • Roche
  • Pfizer Inc.
  • Sage Therapeutics
  • Moderna, Inc.
  • Mylan N.V.
  • Hikma Pharmaceuticals
  • Cipla Limited
  • Aurobindo Pharma

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Generic PrEP
  • Branded PrEP

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET, BY USAGE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Daily Oral PrEP
  • Long-Acting Injectables

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Community Health Centers
  • Specialized HIV Clinics

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pre-Exposure Prophylaxis (PrEP) Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pre-Exposure Prophylaxis (PrEP) Market Snippet by Product Type
    • 2.1.2. Pre-Exposure Prophylaxis (PrEP) Market Snippet by Usage Type
    • 2.1.3. Pre-Exposure Prophylaxis (PrEP) Market Snippet by End User
    • 2.1.4. Pre-Exposure Prophylaxis (PrEP) Market Snippet by Country
    • 2.1.5. Pre-Exposure Prophylaxis (PrEP) Market Snippet by Region
  • 2.2. Competitive Insights

3. Pre-Exposure Prophylaxis (PrEP) Key Market Trends

  • 3.1. Pre-Exposure Prophylaxis (PrEP) Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pre-Exposure Prophylaxis (PrEP) Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pre-Exposure Prophylaxis (PrEP) Market Opportunities
  • 3.4. Pre-Exposure Prophylaxis (PrEP) Market Future Trends

4. Pre-Exposure Prophylaxis (PrEP) Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pre-Exposure Prophylaxis (PrEP) Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Pre-Exposure Prophylaxis (PrEP) Market Landscape

  • 6.1. Pre-Exposure Prophylaxis (PrEP) Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pre-Exposure Prophylaxis (PrEP) Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Generic PrEP
    • 7.1.3. Branded PrEP

8. Pre-Exposure Prophylaxis (PrEP) Market - By Usage Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Usage Type, 2023 & 2032 (%)
    • 8.1.2. Daily Oral PrEP
    • 8.1.3. Long-Acting Injectables

9. Pre-Exposure Prophylaxis (PrEP) Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals and Clinics
    • 9.1.3. Community Health Centers
    • 9.1.4. Specialized HIV Clinics

10. Pre-Exposure Prophylaxis (PrEP) Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Pre-Exposure Prophylaxis (PrEP) Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Gilead Sciences, Inc.
    • 11.2.2. ViiV Healthcare
    • 11.2.3. Bristol-Myers Squibb
    • 11.2.4. Janssen Pharmaceuticals
    • 11.2.5. Merck & Co., Inc.
    • 11.2.6. AbbVie Inc.
    • 11.2.7. Roche
    • 11.2.8. Pfizer Inc.
    • 11.2.9. Sage Therapeutics
    • 11.2.10. Moderna, Inc.
    • 11.2.11. Mylan N.V.
    • 11.2.12. Hikma Pharmaceuticals
    • 11.2.13. Cipla Limited
    • 11.2.14. Aurobindo Pharma

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제